Stock · NSE
BIOCON
415.55▲ 3.05 (0.74%)Last 2 days · 15m candles25/8/2026, 00:35:13
Open: 412.65High: 415.55Low: 411.70Prev: 412.50
VERIFIEDMint Money·1d★ ON YOUR LIST
Mutual funds bet across market caps in July 2026: Torrent Pharma, Biocon and Diamond Power among top stock buysAI summary· NEUTRAL
- ·Mutual funds increased exposure to large-, mid-, and small-cap stocks in July 2026.
- ·Buying activity was observed across sectors such as banking, financial services, and consumer services.
- ·Torrent Pharma, Biocon, and Diamond Power were among the top stock buys for mutual funds.
VERIFIEDET Stocks·6d★ ON YOUR LIST
Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjectorAI summary· POSITIVE
- ·Biocon shares increased by 2% following the USFDA approval.
- ·The approval is for Yesintek single-dose prefilled autoinjectors in two strengths.
- ·This approval enhances Biocon's US immunology product offerings.
VERIFIEDMint Markets·17d★ ON YOUR LIST
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 7 August 2026AI summary· NEUTRAL
- ·Sumeet Bagadia recommends five breakout stocks to buy today.
- ·The recommended stocks are Kalyan Jewellers India, Bharat Dynamics, Union Bank of India, Garden Reach Shipbuilders & Engineers, and Biocon.
- ·The recommendations are for 7 August 2026.
VERIFIEDMint Companies·18d★ ON YOUR LIST
US generics tariffs more negotiation tactic than real threat: Biocon’s Kiran Mazumdar-ShawAI summary· NEUTRAL
- ·Biocon's Kiran Mazumdar-Shaw views US generics tariffs as a negotiation tactic.
- ·The company is in a wait-and-watch mode regarding the tariffs.
- ·Biocon is exploring partnerships for US manufacturing if necessary.
Google News, India stocks·18d★ ON YOUR LIST
Stocks to Watch Today: Aurobindo Pharma, Cohance, Hindalco, Cummins, PB Fintech, Navin Fluorine, Biocon,... - Moneycontrol.comVERIFIEDMint Markets·19d★ ON YOUR LIST
Q1 results 2026: Power Grid to PB Fintech among companies to declare Q1 results today; full list hereAI summary· NEUTRAL
- ·Power Grid Corporation of India will report its Q1 results FY27 today.
- ·Cummins India is among the companies scheduled to declare their Q1 results FY27 today.
- ·PB Fintech will also announce its Q1 results for FY27 today.
VERIFIEDET Finance·26d★ ON YOUR LIST
Biocon gets Health Canada nod for Yesintek autoinjector penAI summary· POSITIVE
- ·Biocon has received Health Canada approval for its Yesintek autoinjector.
- ·The autoinjector is indicated for psoriasis, psoriatic arthritis, and Crohn's disease.
- ·This approval aims to enhance Biocon's immunology product offerings in Canada.
VERIFIEDMint Markets·31d★ ON YOUR LIST
Stocks to buy for short term: Biocon among 3 shares Ajit Mishra of Religare Broking recommends for next 1-2 weeksAI summary· POSITIVE
- ·Ajit Mishra of Religare Broking recommends Biocon, Mahindra, and United Spirits for short-term gains.
- ·These stocks have favorable technical setups.
- ·The stocks show potential for upward momentum in the next 1-2 weeks.
VERIFIEDET Stocks·39d★ ON YOUR LIST
BHEL among 6 midcap stocks that hit 52-week highs and rallied up to 20% in a monthAI summary· POSITIVE
- ·Six BSE 150 MidCap stocks, including BHEL, reached new 52-week highs.
- ·These stocks experienced rallies of up to 20% within the last month.
- ·The performance indicates strong buying interest and sustained bullish momentum in the midcap segment.
VERIFIEDET Markets·39d★ ON YOUR LIST
BHEL among 6 midcap stocks that hit 52-week highs and rallied up to 20% in a monthAI summary· POSITIVE
- ·Six BSE 150 MidCap stocks, including BHEL, reached new 52-week highs.
- ·These stocks experienced rallies of up to 20% within the last month.
- ·The upward movement indicates strong buying interest and sustained bullish momentum.
VERIFIEDET Markets·40d★ ON YOUR LIST
Biocon among 4 stocks showing bullish RSI upswingAI summary· POSITIVE
- ·Four Nifty500 stocks gained over 4% on July 14.
- ·These stocks appeared in the RSI Trending Up scan, indicating improving momentum.
- ·The Relative Strength Index (RSI) moved above 50, signaling strengthening price action.
VERIFIEDET Stocks·41d★ ON YOUR LIST
Rs 1,839 crore Biocon block deal: ICICI Pru MF biggest buyer along with Citi and Goldman SachsAI summary· NEUTRAL
- ·Mylan sold a stake in Biocon worth ₹1,839 crore via a block deal.
- ·ICICI Prudential Mutual Fund was the largest buyer in the block deal.
- ·Other institutional investors including mutual funds, insurers, and foreign investors participated.
VERIFIEDET Stocks·41d★ ON YOUR LIST
Biocon among 4 midcap stocks that hit 52-week highs and rallied up to 21% in a monthAI summary· POSITIVE
- ·Four BSE 150 Midcap stocks, including Biocon, reached new 52-week highs on Tuesday.
- ·These stocks showed strong buying interest and bullish momentum.
- ·The rally occurred despite a 561-point fall in the Sensex on the same day.
VERIFIEDET Stocks·41d★ ON YOUR LIST
Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake saleAI summary· POSITIVE
- ·Biocon shares surged over 6% on Tuesday.
- ·Mylan, owned by Viatris, plans to sell its 5.64% stake in Biocon.
- ·Block deals involving nearly nine crore shares were observed in early trading.
Google News, India stocks·41d★ ON YOUR LIST
Stock Market Live: Nifty below 24,100, Sensex down 450 pts; HCLTech down 2%, Biocon up 3% - Moneycontrol.comGoogle News, NIFTY/SENSEX·41d★ ON YOUR LIST
GIFT Nifty Slips 165 Points; HCL Tech, Biocon Stocks in Focus - NiftyTraderVERIFIEDET Markets·41d★ ON YOUR LIST
Stocks in news: Tata Elxsi, HCL Tech, ICICI Pru AMC, Biocon, SpiceJetAI summary· NEUTRAL
- ·HCL Tech reported a twenty percent year-on-year net profit growth and declared an interim dividend.
- ·ICICI Prudential AMC saw a twenty-three percent net profit increase in its first quarter.
- ·SpiceJet faces aircraft deregistration requests, while Biocon plans a significant share sale.
Google News, India stocks·42d★ ON YOUR LIST
Stocks to Watch Today: HCL Tech, Biocon, Timken India, EMS, Alembic Pharma, PDS, ICICI Prudential AMC,... - Moneycontrol.comVERIFIEDMint Companies·42d★ ON YOUR LIST
Mylan launches block deal to sell minority stake in Biocon for up to $363 millionAI summary· NEUTRAL
- ·Mylan, through its Viatris arm, is launching a block deal to sell its minority stake in Biocon.
- ·The deal aims to offload 92 million equity shares.
- ·This move represents a financial exit for Mylan following biosimilar asset integrations.
VERIFIEDET Stocks·42d★ ON YOUR LIST
Mylan to sell up to $363 million stake in India's Biocon, term sheet showsAI summary· NEUTRAL
- ·Mylan plans to sell up to 92 million shares in Biocon.
- ·The stake sale is valued at up to 34.81 billion Indian rupees.
- ·The stake sale is worth up to $363 million.
VERIFIEDET Stocks·42d★ ON YOUR LIST
Paytm among 5 F&O stocks with a sharp rise in futures open interestAI summary· NEUTRAL
- ·Five NSE F&O stocks saw over 6% growth in futures open interest on July 10.
- ·Paytm, CDSL, and Biocon were among the stocks experiencing this rise.
- ·This indicates fresh positioning and increased trader participation.
VERIFIEDMint Companies·49d★ ON YOUR LIST
True North cashes out $2 billion for investors as PE firms step up exitsAI summary· POSITIVE
- ·True North has returned $2 billion to investors.
- ·This return is attributed to exits from several portfolio companies.
- ·Exited companies include FedFina, Niva Bupa, Biocon Biologics, Infinity Fincorp Solutions, Zydus Wellness, and Home First Finance.
VERIFIEDEconomic Times News·49d★ ON YOUR LIST
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800AI summary· POSITIVE
- ·Analysts suggest a buy-on-dips strategy for the Nifty around the 24,000-24,150 range.
- ·Potential upside targets for the Nifty are projected to reach 24,800.
- ·Several stocks, including Container Corporation of India and IndusInd Bank, are recommended with specific price targets.
VERIFIEDET Stocks·49d★ ON YOUR LIST
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800AI summary· POSITIVE
- ·Analysts anticipate the Nifty to continue its upward trend.
- ·They suggest buying on dips around the 24,000-24,150 mark.
- ·Potential upside targets for the Nifty are seen reaching 24,800.
VERIFIEDET Markets·49d★ ON YOUR LIST
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800AI summary· POSITIVE
- ·Analysts suggest a buy-on-dips strategy for the Nifty around the 24,000-24,150 range.
- ·Potential upside targets for the Nifty are projected to reach 24,800.
- ·Several stocks, including Container Corporation of India and IndusInd Bank, are recommended with specific price targets.
Google News, SEBI·59d★ ON YOUR LIST
Supreme Court upholds SAT relief for former Biocon executive in insider trading case - The New Indian ExpressVERIFIEDMint Markets·62d★ ON YOUR LIST
Buy or sell: Gift Nifty signals gap-up opening, Vaishali Parekh recommends three stocks to buy today — 23 June 2026AI summary· NEUTRAL
- ·Gift Nifty signals a gap-up opening for the Indian stock market.
- ·Vaishali Parekh has recommended three stocks for trading today.
- ·The recommended stocks are Hindustan Zinc, Biocon, and Adani Green Energy.
VERIFIEDET Markets·63d★ ON YOUR LIST
Laurus Labs, Biocon, Ather Energy, Lenskart among probable MSCI India Standard Index inclusion candidates, says JM FinancialAI summary· NEUTRAL
- ·JM Financial expects Laurus Labs and Biocon to be added to the MSCI India Standard Index.
- ·Ather Energy and SAIL are considered medium-probability candidates for inclusion.
- ·SBI Card has a high probability of being excluded from the index.
VERIFIEDET Stocks·63d★ ON YOUR LIST
Laurus Labs, Biocon, Ather Energy, Lenskart among probable MSCI India Standard Index inclusion candidates, says JM FinancialAI summary· NEUTRAL
- ·JM Financial expects Laurus Labs and Biocon to be added to the MSCI India Standard Index.
- ·Ather Energy and SAIL are considered medium-probability candidates for inclusion.
- ·SBI Card has a high probability of being excluded from the index.
VERIFIEDMint Companies·69d★ ON YOUR LIST
Biocon eyes crown of world’s top insulin supplier amid rush for GLP-1AI summary· NEUTRAL
- ·Biocon is currently the third-largest insulin supplier globally by volume.
- ·The company has significantly invested in increasing its production capacity.
- ·Chairperson Kiran Mazumdar-Shaw highlighted the company's focus on insulin supply amidst the demand for GLP-1 drugs.